Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer

This study has been terminated.
(Lack of drug supply for doxercalciferol for this study)
Sponsor:
Collaborators:
Sanofi
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00582582
First received: December 19, 2007
Last updated: September 30, 2015
Last verified: April 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2007
  Estimated Primary Completion Date: No date given